Is a complete BIVI research report available?

No complete published report is available for BioVie Inc. (BIVI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

BioVie Inc. (BIVI)

NASDAQ: BIVI · USD

$1.37

-0.07 (-4.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BIVI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	10.3M
Net income (ttm)	-20M
EPS (ttm)	-$3.49
Shares out	7.5M
Volume	111,984
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -20M
EPS (ttm): -$3.49
Market cap: 10.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BIVI indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

USD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001580149
Company name	BioVie Inc.
Country	United States
Country code	US
Cusip	09074F504
Employees	13
Employees Change	-1%
Employees Change Percent	-7.14
Enterprise value	$-2.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US09074F5044
Last refreshed	2026-07-26
Market cap	$10.3M
Market cap category	Nano-Cap
Price	$1.37
Price currency	USD
Sector	Healthcare
Sector PE	44.87
Sector PE Fwd	23.76
Sic	2834
Symbol	BIVI
Website	https://bioviepharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-193.18%
P/B ratio	0.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-20M
Net Income Growth Years	2%
Profit Per Employee	$-1.5M
ROA	-61.04
Roa5y	-493.9
ROCE	-130.2
ROE	-106.4
ROIC	-67.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-51.43%
Cagr1y	-83.39%
Cagr3y	-86.04%
Cagr5y	-75.56%
EPS Growth Quarters	12
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$17.5M
Cash	$13.1M
Current Assets	$16.9M
Current Liabilities	$1.7M
Debt	$295,717
Debt Equity	$0.02
Equity	$15.6M
Interest Coverage	-1,088.5
Liabilities	$1.9M
Long Term Assets	$634,929
Long Term Liabilities	$213,319
Net Cash	$12.8M
Net Cash By Market Cap	$124
Net Cash Growth	-43.81%
Net Debt Equity	$-0.82
Tangible Book Value	$15.3M
Tangible Book Value Per Share	$2.02
WACC	7.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.97
Net Working Capital	$2.2M
Quick ratio	9.02
Working Capital	$15.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-391.54%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.93%
1Y total return	-83.37%
200-day SMA	1.51
3Y total return	-99.73%
50-day SMA	1.68
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.91%
All Time High	6,875
All Time High Change	-99.98%
All Time High Date	2014-07-17
All Time Low	1.06
All Time Low Change	29.25%
All Time Low Date	2026-02-05
ATR	0.21
Beta	0.58
Beta1y	0.15
Beta2y	1.6
Ch YTD	18.1
High	1.49
High52	8.4
High52 Date	2025-07-24
High52ch	-83.69%
Low	1.34
Low52	1.06
Low52 Date	2026-02-05
Low52ch	29.25%
Ma50ch	-18.6%
Premarket Change Percent	1.24
Premarket Price	$1.46
Premarket Volume	1,008
Price vs 200-day SMA	-9.09%
RSI	39.55
RSI Monthly	37.48
RSI Weekly	41.77
Sharpe ratio	-1.26x
Sortino ratio	-1.47
Total Return	-391.54%
Tr YTD	18.1
Tr1m	-29.38%
Tr1w	-23.89%
Tr3m	-4.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-20.6M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,501,954%
Float Percent	99.47%
Net Borrowing	2,901,341
Shares Insiders	0.53%
Shares Institutions	13.68%
Shares Out	7,541,839
Shares Qo Q	-4.76%
Shares Yo Y	391.54%
Short Float	5.99%
Short Ratio	2.61
Short Shares	5.95

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	216,263.1x
Bv Per Share	2.07
Ch10y	-99.93
Ch1m	-29.38
Ch1w	-23.89
Ch1y	-83.37
Ch3m	-4.2
Ch3y	-99.73
Ch5y	-99.91
Ch6m	12.3
Change	-4.86%
Change From Open	-5.52
Close	1.44
Days Gap	0.69
Depreciation Amortization	229,377
Dollar Volume	153,418.1
Earnings Date	2026-08-14
Earnings Time	amc
EBIT	$-20.6M
EBITDA	$-20.4M
EPS	$-3.49
F Score	1
Financing CF	10,457,629
Fiscal Year End	June
Founded	2,013
Goodwill	345,711
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-11
Last Report Date	2026-03-31
Last Split Date	2025-07-07
Last Split Type	Reverse
Last10k Filing Date	2025-08-15
Ma150	1.46
Ma150ch	-6.23%
Ma20	1.82
Ma20ch	-24.6%
Net CF	-10,053,038
Next Earnings Date	2026-08-14
Open	1.45
Optionable	No
Position In Range	20
Post Close	1.37
Postmarket Change Percent	1.46
Postmarket Price	$1.39
Ppne	282,910
Pre Close	1.44
Price Date	2026-07-24
Ptbv Ratio	0.68
Relative Volume	0.52x
Share Based Comp	3,248,490
Tr6m	12.3%
Us State	Nevada
Volume	111,984

BioVie Inc. (BIVI)

Coverage state: Market snapshot only — no published research

Generate the first BIVI analysis

Price

Financial snapshot

Fair-value bridge

Latest news · BIVI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIVI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BIVI

Frequently asked questions